{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-256014","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.095781+00:00","generated_at":"2026-05-30T02:30:51.472451+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Teva elects Chen Lichtenstein to board effective Dec 1, 2024","bullets":["Chen Lichtenstein elected as independent director, effective Dec 1, 2024, until 2025 annual meeting.","Lichtenstein was CFO of Syngenta Group (2020-2023) and previously CEO of ADAMA Ltd.","He holds a Ph.D. in Business Administration from Stanford and multiple degrees from Hebrew University.","Compensation will be the same as Teva's other non-executive directors.","No material related-party transactions or family relationships with Teva executives."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-256014","json":"https://secwatch.observer/filing/0001193125-24-256014.json","markdown":"https://secwatch.observer/filing/0001193125-24-256014.md","text":"https://secwatch.observer/filing/0001193125-24-256014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312524256014/0001193125-24-256014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312524256014/d853506d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:30:51.472451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec55922d7f","claim":"Chen Lichtenstein was elected as member of the Board at TEVA PHARMACEUTICAL INDUSTRIES LTD.","evidence_excerpt":"the Board elected Mr. Chen Lichtenstein to serve as a member of the Board, effective December 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312524256014/0001193125-24-256014-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"member of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}